U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501884) titled 'REDUCER Trial (TXA in Urethroplasty)' on March 21.
Brief Summary: This study will test whether tranexamic acid (TXA), a medication used to reduce bleeding, can decrease blood loss in patients having urethroplasty. Participants will be randomly assigned to receive either a single intravenous dose of TXA at the start of anesthesia or standard care without TXA. Researchers will compare hemoglobin change after surgery as well as estimated blood loss and complications.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Urethral Stricture
Urethral Diseases
Intervention:
DRUG: Tranexamic Acid
Tranexamic acid (TXA) will ...